Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multi-Center Study of Weight-Reducing Effect and Safety in Obese Patients With Untreated Dyslipidemias

NCT00029835 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00029835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00029835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multi-Center Study of Weight-Reducing Effect and Safety in Obese Patients With Untreated Dyslipidemias
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2001
Completion date
November 30, 2003
Enrollment
1,033 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemia, obesity